ATHE
Alterity Therapeutics LtdCompany with tickers: ATHE, PRNAF
CIK
1131343
CUSIP
02155X205
Shares Outstanding
18,125,694
13F Activity (30d)
11 filings
11 filers
Price
$4.16
Market Cap
$78.28M
52W High
$7.00
52W Low
$2.66
Price History
Institutional Holders
Short Volume
Short Interest
Fails to Deliver
Financials
SEC Filings
Earnings Calls
Insider Trades
Congressional Trades
| Date | Insider | Role | Type | Shares |
|---|---|---|---|---|
| 2026-04-17 | Cunningham Ann Michelle | Director | Other | 0 |
| 2026-04-15 | Stamler David Allen | Director, Chief Executive Officer | Other | 0 |
| 2026-04-15 | Stamler David Allen | Director, Chief Executive Officer | Other | 11,688,312 |
| 2026-04-15 | Stamler David Allen | Director, Chief Executive Officer | Other | 0 |
| 2026-04-15 | Stamler David Allen | Director, Chief Executive Officer | Other | 0 |
| 2026-04-15 | Stamler David Allen | Director, Chief Executive Officer | Other | 139,258 |
| 2026-04-15 | Stamler David Allen | Director, Chief Executive Officer | Other | 0 |
| 2026-04-10 | Gozlan Lawrence Bernard | Director | Other | 4,545,455 |
| 2026-04-10 | Gozlan Lawrence Bernard | Director | Other | 0 |
| 2026-04-10 | Gozlan Lawrence Bernard | Director | Other | 0 |
| 2026-04-10 | Babarczy Julian Michael | Director | Other | 0 |
| 2026-04-10 | Marks Peter Ashley | Director | Other | 1,818,182 |
| 2026-04-10 | Marks Peter Ashley | Director | Other | 0 |
| 2026-04-10 | Marks Peter Ashley | Director | Other | 0 |
| 2026-04-09 | Macnish Niven Abby Sarah | Chief Financial Officer | Other | 0 |
| 2026-04-09 | Macnish Niven Abby Sarah | Chief Financial Officer | Other | 454,545 |